Nikolaus Gassler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nikolaus Gassler has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Frank Autschbach
Department of Pathology, University of Heidelberg, D-69120 Heidelberg, Germany
4 shared publicationsJürgen Kartenbeck
3 shared publicationsAlexis Ulrich
Department of Surgery, University of Heidelberg, D-69120 Heidelberg, Germany
2 shared publicationsB. M. Helmke
2 shared publicationsF. Autschbach
Universität Heidelberg
2 shared publicationsHerwart F Otto
Department of Pathology, University of Heidelberg, Heidelberg, Germany
2 shared publications
Latest Publications
- Open Access
- 16 October 2023
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 63 (6) , 1
[Corrigendum] Wnt‑signaling and apoptosis after neoadjuvant short‑term radiotherapy for rectal cancer
Subsequently to the publication of the above article, an interested reader drew to the authors' attention that, for the images shown to represent different immunostaining experiments in fig. 1b and e (the 'group 2' experiments), the images were overlapping, which seemed to suggest that either the image for β-catenin or the image for c-Myc did not accurately represent the results of the experiment in question. after having reexamined their original data, the authors have realized that an error was inadvertently made during the assembly of this figure; namely, that Fig. 1E showed a section of Fig. 1B at a higher magnification (both images showed β-catenin immunostaining). the revised version of fig. 1, correctly showing the results of the β-catenin immunostaining experiment in fig. 1b and the c-Myc immunostaining experiment in fig. 1e, is shown on the next page.
- 16 October 2023
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 63 (6) , 1
Open Access[Corrigendum] Wnt‑signaling and apoptosis after neoadjuvant short‑term radiotherapy for rectal cancer
Subsequently to the publication of the above article, an interested reader drew to the authors' attention that, for the images shown to represent different immunostaining experiments in fig. 1b and e (the 'group 2' experiments), the images were overlapping, which seemed to suggest that either the image for β-catenin or the image for c-Myc did not accurately represent the results of the experiment in question. after having reexamined their original data, the authors have realized that an error was inadvertently made during the assembly of this figure; namely, that Fig. 1E showed a section of Fig. 1B at a higher magnification (both images showed β-catenin immunostaining). the revised version of fig. 1, correctly showing the results of the β-catenin immunostaining experiment in fig. 1b and the c-Myc immunostaining experiment in fig. 1e, is shown on the next page.
- 13 November 2006
- Published by Georg Thieme Verlag KG in Neuropediatrics
- Vol. 210 (S 5) , V54
Erhöhte pulmonale DMBT1-Expression bei Infektionen von Frühgeborenen und DMBT1-bedingte negative Modulation der Surfactantfunktion
Fragestellung: Die primäre und sekundäre Surfactantdefizienz hat wesentlichen Anteil an der Morbidität und Letalität unreifer Frühgeborener. Insbesondere inflammatorische Prozesse tragen durch die Modulation von Surfactantfunktionen zu einer Verschlechterung der pulmonalen Situation bei. Das Glykoprotein DMBT1 (Deleted in Malignant Brain Tumors1) gehört zu der Gruppe B der scavenger receptor cysteine-rich Familie. Es spielt eine Rolle bei der Immunabwehr an mukosalen Oberflächen, indem es zahlreiche Bakterien und Viren bindet und agglutiniert. Ebenso interagiert es mit den Surfactantproteinen A und D, trägt zur Aktivierung der Chemokinese alveolärer Makrophagen bei und vermittelt die Aktivierung des Komplementsystems. Wir konnten mittels enzyme-linked immunosorbent assay (ELISA) nachweisen, dass bei einer Infektion im Trachealsekret frühgeborener Kinder hochsignifikant erhöhte DMBT1-Level vorliegen. Wir untersuchten die DMBT1-Expression im Lungengewebe verstorbener Früh- und Reifgeborener und bestimmten den Einfluss von DMBT1 auf die Funktion von Surfactant. Methodik: Mittels Immunhistochemie wurde die DMBT1-Expression in Lungenschnitten von 17 verstorbenen Früh- und Reifgeborenen unter Verwendung der Antikörper anti-DMBT1h12 (monoklonal) und anti-DMBT1p84 (polyklonal), die gegen verschiedene Regionen des Proteins gerichtet sind, untersucht. Den Einfluss von humanem rekombinanten DMBT1 (hrDMBT1) auf Rinder- und Schweinesurfactant (Alveofact, Curosurf) analysierten wir mithilfe eines capillary surfactometers (Calmia Medical, Toronto, ON, Canada). Ergebnisse: Die immunhistochemischen Analysen zeigten eine erhöhte DMBT1-Expression der Alveolen, Bronchiolen und Bronchien bei den Frühgeborenen mit Infektion im Vergleich zu denen ohne Infektion. hrDMBT1 erhöhte in vitro die Oberflächenspannung von Alveofact und Curosurf. Zugabe von Calcium inhibierte diesen Effekt. Dabei wurde – im Vergleich zu Curosurf – die Funktion von Alveofact durch geringere DMBT1-Mengen (100µg/ml vs. 200µg/ml) beeinflusst, und es war eine höhere Calcium-Menge (5mM CaCl2 vs. 1mM CaCl2) erforderlich, um die Surfactant-Funktion wiederherzustellen. Schlussfolgerung: Unsere Daten weisen darauf hin, dass die erhöhte Expression von DMBT1 in der Lunge bei Frühgeborenen mit Infektion zu einer nachteiligen Modulation der Funktion von bereits vorhandenem endogenen oder appliziertem exogenen Surfactant beitragen könnte.
- 13 November 2006
- Published by Georg Thieme Verlag KG in Neuropediatrics
- Vol. 210 (S 5) , V54
Erhöhte pulmonale DMBT1-Expression bei Infektionen von Frühgeborenen und DMBT1-bedingte negative Modulation der Surfactantfunktion
Fragestellung: Die primäre und sekundäre Surfactantdefizienz hat wesentlichen Anteil an der Morbidität und Letalität unreifer Frühgeborener. Insbesondere inflammatorische Prozesse tragen durch die Modulation von Surfactantfunktionen zu einer Verschlechterung der pulmonalen Situation bei. Das Glykoprotein DMBT1 (Deleted in Malignant Brain Tumors1) gehört zu der Gruppe B der scavenger receptor cysteine-rich Familie. Es spielt eine Rolle bei der Immunabwehr an mukosalen Oberflächen, indem es zahlreiche Bakterien und Viren bindet und agglutiniert. Ebenso interagiert es mit den Surfactantproteinen A und D, trägt zur Aktivierung der Chemokinese alveolärer Makrophagen bei und vermittelt die Aktivierung des Komplementsystems. Wir konnten mittels enzyme-linked immunosorbent assay (ELISA) nachweisen, dass bei einer Infektion im Trachealsekret frühgeborener Kinder hochsignifikant erhöhte DMBT1-Level vorliegen. Wir untersuchten die DMBT1-Expression im Lungengewebe verstorbener Früh- und Reifgeborener und bestimmten den Einfluss von DMBT1 auf die Funktion von Surfactant. Methodik: Mittels Immunhistochemie wurde die DMBT1-Expression in Lungenschnitten von 17 verstorbenen Früh- und Reifgeborenen unter Verwendung der Antikörper anti-DMBT1h12 (monoklonal) und anti-DMBT1p84 (polyklonal), die gegen verschiedene Regionen des Proteins gerichtet sind, untersucht. Den Einfluss von humanem rekombinanten DMBT1 (hrDMBT1) auf Rinder- und Schweinesurfactant (Alveofact, Curosurf) analysierten wir mithilfe eines capillary surfactometers (Calmia Medical, Toronto, ON, Canada). Ergebnisse: Die immunhistochemischen Analysen zeigten eine erhöhte DMBT1-Expression der Alveolen, Bronchiolen und Bronchien bei den Frühgeborenen mit Infektion im Vergleich zu denen ohne Infektion. hrDMBT1 erhöhte in vitro die Oberflächenspannung von Alveofact und Curosurf. Zugabe von Calcium inhibierte diesen Effekt. Dabei wurde – im Vergleich zu Curosurf – die Funktion von Alveofact durch geringere DMBT1-Mengen (100µg/ml vs. 200µg/ml) beeinflusst, und es war eine höhere Calcium-Menge (5mM CaCl2 vs. 1mM CaCl2) erforderlich, um die Surfactant-Funktion wiederherzustellen. Schlussfolgerung: Unsere Daten weisen darauf hin, dass die erhöhte Expression von DMBT1 in der Lunge bei Frühgeborenen mit Infektion zu einer nachteiligen Modulation der Funktion von bereits vorhandenem endogenen oder appliziertem exogenen Surfactant beitragen könnte.
- 1 May 2006
- Published by Springer Nature in Der Pathologe
- Vol. 27 (3) , 217-221
Onkozytom der Niere mit Metastase eines Mammakarzinoms
- 1 May 2006
- Published by Springer Nature in Der Pathologe
- Vol. 27 (3) , 217-221
Onkozytom der Niere mit Metastase eines Mammakarzinoms
- 5 April 2005
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 21 (2) , 130-134
Coeliac disease is associated with impaired expression of acyl-CoA-synthetase 5
Background and aims Coeliac disease and other disorders of the small intestine are associated with disturbances in mucosal architecture. The most severe injury to tissue architecture is villus atrophy. In coeliac disease, molecules reflecting the state of the villus architecture are not well characterized at present. Materials and methods Expression of acyl-CoA-synthetase 5 (ACS5) was studied in unaffected human small/large intestinal tissue and in coeliac disease using several methods including molecular techniques, as well as an in situ approach using a novel established monoclonal antibody directed against human ACS5. Results Strong expression, synthesis, and enzymatic activity of ACS5 were found in normal small intestinal mucosa compared with unaffected colon mucosa. In normal small intestine, ACS5 preferentially located to the epithelium covering villi. In coeliac disease, expression of ACS5 was regularly associated with differentiation of villi. Thus, ACS5 was found in the villus epithelium of the small intestine with coeliac disease of Marsh grades I, II, IIIa, or IIIb respectively. In Marsh grade IIIc coeliac disease lesions, strong expression of ACS5 was detectable neither in the surface epithelium nor in the epithelium lining hyperplastic crypts. Conclusion These data suggest that ACS5 is a very suitable marker molecule for the detection of villus atrophy in the small intestine.
- 5 April 2005
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 21 (2) , 130-134
Coeliac disease is associated with impaired expression of acyl-CoA-synthetase 5
Background and aims Coeliac disease and other disorders of the small intestine are associated with disturbances in mucosal architecture. The most severe injury to tissue architecture is villus atrophy. In coeliac disease, molecules reflecting the state of the villus architecture are not well characterized at present. Materials and methods Expression of acyl-CoA-synthetase 5 (ACS5) was studied in unaffected human small/large intestinal tissue and in coeliac disease using several methods including molecular techniques, as well as an in situ approach using a novel established monoclonal antibody directed against human ACS5. Results Strong expression, synthesis, and enzymatic activity of ACS5 were found in normal small intestinal mucosa compared with unaffected colon mucosa. In normal small intestine, ACS5 preferentially located to the epithelium covering villi. In coeliac disease, expression of ACS5 was regularly associated with differentiation of villi. Thus, ACS5 was found in the villus epithelium of the small intestine with coeliac disease of Marsh grades I, II, IIIa, or IIIb respectively. In Marsh grade IIIc coeliac disease lesions, strong expression of ACS5 was detectable neither in the surface epithelium nor in the epithelium lining hyperplastic crypts. Conclusion These data suggest that ACS5 is a very suitable marker molecule for the detection of villus atrophy in the small intestine.
- 1 December 2004
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 25 (6) , 1543-1549
Wnt-signaling and apoptosis after neoadjuvant short-term radiotherapy for rectal cancer.
Recent surgical concepts for primary rectal cancer include the combination of surgery and short-term neoadjuvant radiotherapy (STNR). This is usually given in a dose of 25 Gy over five days in order to reduce local recurrence rates. Clinical studies have shown that local recurrence is found in some patients despite STNR. We identified molecular patterns of the Wnt- and apoptosis pathways as well as expression of junction-associated molecules in rectal cancer specimens of patients who received STNR and in those who did not. Expression patterns were examined by immunohistochemistry and molecular techniques such as LightCycler RT-PCR and Western blot analysis in 25 sporadic rectal adenocarcinoma specimens derived from STNR-patients or non-pretreated donors, respectively. The molecular pattern in response to STNR was heterogeneous and was reflected by responders who show activation of apoptosis and cellular remodeling, whereas the group of non-responders from STNR did not show such reaction and was very similar to untreated controls. Enhanced expression of beta-catenin was generally mediated by STNR, but exclusively in the responder group impaired expression of c-Myc and junction-associated molecules as well as cleavage of poly-ADP-ribose polymerase and of the caspase substrate cytokeratin 19 were found. The molecular profile suggests that STNR interferes with Wnt-signaling and c-Myc expression. STNR in its present form is not suitable to fully complete the sequence of apoptosis in all rectal adenocarcinomas.
- 1 December 2004
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 25 (6) , 1543-1549
Wnt-signaling and apoptosis after neoadjuvant short-term radiotherapy for rectal cancer.
Recent surgical concepts for primary rectal cancer include the combination of surgery and short-term neoadjuvant radiotherapy (STNR). This is usually given in a dose of 25 Gy over five days in order to reduce local recurrence rates. Clinical studies have shown that local recurrence is found in some patients despite STNR. We identified molecular patterns of the Wnt- and apoptosis pathways as well as expression of junction-associated molecules in rectal cancer specimens of patients who received STNR and in those who did not. Expression patterns were examined by immunohistochemistry and molecular techniques such as LightCycler RT-PCR and Western blot analysis in 25 sporadic rectal adenocarcinoma specimens derived from STNR-patients or non-pretreated donors, respectively. The molecular pattern in response to STNR was heterogeneous and was reflected by responders who show activation of apoptosis and cellular remodeling, whereas the group of non-responders from STNR did not show such reaction and was very similar to untreated controls. Enhanced expression of beta-catenin was generally mediated by STNR, but exclusively in the responder group impaired expression of c-Myc and junction-associated molecules as well as cleavage of poly-ADP-ribose polymerase and of the caspase substrate cytokeratin 19 were found. The molecular profile suggests that STNR interferes with Wnt-signaling and c-Myc expression. STNR in its present form is not suitable to fully complete the sequence of apoptosis in all rectal adenocarcinomas.
- 1 March 2004
- Published by Springer Nature in Der Pathologe
- Vol. 25 (2) , 155-159
Sekundäres malignes Melanom der Gallenblase
- 1 March 2004
- Published by Springer Nature in Der Pathologe
- Vol. 25 (2) , 155-159
Sekundäres malignes Melanom der Gallenblase
- 19 January 2004
- Published by Wiley in The Journal of Pathology
- Vol. 202 (2) , 188-196
Expression of acyl‐CoA synthetase 5 reflects the state of villus architecture in human small intestine
Several disorders of the small intestine are associated with disturbances in villus architecture. Thus, an understanding of the molecular mechanisms associated with the differentiation of villi represents an important step in the improvement of the understanding of small intestinal pathology. Screening of antibodies from a hybridoma library led to the identification of an acyl‐CoA synthetase 5‐specific monoclonal antibody. Protein synthesis, mRNA expression, and the enzyme activity of acyl‐CoA synthetase 5 were studied by several methods in human small intestinal tissues with Crohn's disease or coeliac disease, respectively. Acyl‐CoA synthetase 5 mRNA and protein levels were substantially reduced in injured small intestinal mucosa. Moreover, impaired synthesis of the acyl‐CoA synthetase 5 protein was reflected by a decrease in intramucosal enzyme activity. Subtle changes of the acyl‐CoA synthetase 5 pattern correlate with conversion of intestinal epithelial cells to a gastric phenotype. These results suggest that deranged acyl‐CoA synthetase 5 expression, synthesis, and activity are closely related to the state of villus architecture and epithelial homeostasis in human small intestine. Copyright © 2004 John Wiley & Sons, Ltd.
- 19 January 2004
- Published by Wiley in The Journal of Pathology
- Vol. 202 (2) , 188-196
Expression of acyl‐CoA synthetase 5 reflects the state of villus architecture in human small intestine
Several disorders of the small intestine are associated with disturbances in villus architecture. Thus, an understanding of the molecular mechanisms associated with the differentiation of villi represents an important step in the improvement of the understanding of small intestinal pathology. Screening of antibodies from a hybridoma library led to the identification of an acyl‐CoA synthetase 5‐specific monoclonal antibody. Protein synthesis, mRNA expression, and the enzyme activity of acyl‐CoA synthetase 5 were studied by several methods in human small intestinal tissues with Crohn's disease or coeliac disease, respectively. Acyl‐CoA synthetase 5 mRNA and protein levels were substantially reduced in injured small intestinal mucosa. Moreover, impaired synthesis of the acyl‐CoA synthetase 5 protein was reflected by a decrease in intramucosal enzyme activity. Subtle changes of the acyl‐CoA synthetase 5 pattern correlate with conversion of intestinal epithelial cells to a gastric phenotype. These results suggest that deranged acyl‐CoA synthetase 5 expression, synthesis, and activity are closely related to the state of villus architecture and epithelial homeostasis in human small intestine. Copyright © 2004 John Wiley & Sons, Ltd.
- Open Access
- 1 December 2002
- Published by Elsevier in Laboratory Investigation
- Vol. 82 (12) , 1647-1659
Expression of Calnexin Reflects Paneth Cell Differentiation and Function
- 1 December 2002
- Published by Elsevier in Laboratory Investigation
- Vol. 82 (12) , 1647-1659
Open AccessExpression of Calnexin Reflects Paneth Cell Differentiation and Function